Production (Stage)
Senti Biosciences, Inc.
SNTI
$3.11
-$0.10-3.12%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -16.52% | 96.74% | -93.43% | 40.08% | 35.31% |
| Total Depreciation and Amortization | -5.89% | -1.02% | -19.34% | 21.14% | 5.92% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 205.61% | -405.26% | 1,076.84% | -133.91% | -136.75% |
| Change in Net Operating Assets | -453.50% | -124.39% | 622.64% | 171.02% | 136.27% |
| Cash from Operations | -20.27% | -91.90% | 48.85% | 38.98% | 28.35% |
| Capital Expenditure | -- | -175.00% | 100.00% | 100.00% | 99.77% |
| Sale of Property, Plant, and Equipment | -- | -100.00% | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -110.89% | -99.72% | -100.00% | 99.84% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | 8,371.33% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | 9,124.82% | 10,708.70% | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -23.66% | 692.08% | -193.48% | -269.03% | 54.73% |